S&P 500   4,594.63 (+0.59%)
DOW   36,245.50 (+0.82%)
QQQ   389.94 (+0.29%)
AAPL   191.24 (+0.68%)
MSFT   374.51 (-1.16%)
META   324.82 (-0.71%)
GOOGL   131.86 (-0.51%)
AMZN   147.03 (+0.64%)
TSLA   238.83 (-0.52%)
NVDA   467.65 (-0.01%)
NIO   7.16 (-1.51%)
BABA   73.98 (-1.20%)
AMD   121.39 (+0.19%)
T   16.77 (+1.21%)
F   10.58 (+3.02%)
MU   75.93 (-0.25%)
CGC   0.62 (+10.75%)
GE   122.50 (+0.57%)
DIS   92.55 (-0.15%)
AMC   6.87 (+3.16%)
PFE   28.91 (-5.12%)
PYPL   59.65 (+3.54%)
XOM   102.99 (+0.24%)
S&P 500   4,594.63 (+0.59%)
DOW   36,245.50 (+0.82%)
QQQ   389.94 (+0.29%)
AAPL   191.24 (+0.68%)
MSFT   374.51 (-1.16%)
META   324.82 (-0.71%)
GOOGL   131.86 (-0.51%)
AMZN   147.03 (+0.64%)
TSLA   238.83 (-0.52%)
NVDA   467.65 (-0.01%)
NIO   7.16 (-1.51%)
BABA   73.98 (-1.20%)
AMD   121.39 (+0.19%)
T   16.77 (+1.21%)
F   10.58 (+3.02%)
MU   75.93 (-0.25%)
CGC   0.62 (+10.75%)
GE   122.50 (+0.57%)
DIS   92.55 (-0.15%)
AMC   6.87 (+3.16%)
PFE   28.91 (-5.12%)
PYPL   59.65 (+3.54%)
XOM   102.99 (+0.24%)
S&P 500   4,594.63 (+0.59%)
DOW   36,245.50 (+0.82%)
QQQ   389.94 (+0.29%)
AAPL   191.24 (+0.68%)
MSFT   374.51 (-1.16%)
META   324.82 (-0.71%)
GOOGL   131.86 (-0.51%)
AMZN   147.03 (+0.64%)
TSLA   238.83 (-0.52%)
NVDA   467.65 (-0.01%)
NIO   7.16 (-1.51%)
BABA   73.98 (-1.20%)
AMD   121.39 (+0.19%)
T   16.77 (+1.21%)
F   10.58 (+3.02%)
MU   75.93 (-0.25%)
CGC   0.62 (+10.75%)
GE   122.50 (+0.57%)
DIS   92.55 (-0.15%)
AMC   6.87 (+3.16%)
PFE   28.91 (-5.12%)
PYPL   59.65 (+3.54%)
XOM   102.99 (+0.24%)
S&P 500   4,594.63 (+0.59%)
DOW   36,245.50 (+0.82%)
QQQ   389.94 (+0.29%)
AAPL   191.24 (+0.68%)
MSFT   374.51 (-1.16%)
META   324.82 (-0.71%)
GOOGL   131.86 (-0.51%)
AMZN   147.03 (+0.64%)
TSLA   238.83 (-0.52%)
NVDA   467.65 (-0.01%)
NIO   7.16 (-1.51%)
BABA   73.98 (-1.20%)
AMD   121.39 (+0.19%)
T   16.77 (+1.21%)
F   10.58 (+3.02%)
MU   75.93 (-0.25%)
CGC   0.62 (+10.75%)
GE   122.50 (+0.57%)
DIS   92.55 (-0.15%)
AMC   6.87 (+3.16%)
PFE   28.91 (-5.12%)
PYPL   59.65 (+3.54%)
XOM   102.99 (+0.24%)
Positive News SentimentPositive News

Applied Therapeutics (APLT) News Today

$2.42
+0.31 (+14.69%)
(As of 12/1/2023 ET)
Compare
Today's Range
$2.10
▼
$2.45
50-Day Range
$1.84
▼
$2.83
52-Week Range
$0.70
▼
$3.11
Volume
790,082 shs
Average Volume
521,193 shs
Market Capitalization
$186.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability
SourceHeadline
msn.com logoApplied Therapeutics GAAP EPS of -$0.47 misses by $0.21
msn.com - November 9 at 10:25 AM
benzinga.com logoApplied Therapeutics: Q3 Earnings Insights
benzinga.com - November 9 at 10:25 AM
finance.yahoo.com logoApplied Therapeutics Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 9 at 10:25 AM
finance.yahoo.com logoApplied Therapeutics Inc (APLT) Reports Q3 2023 Financial Results Amidst Upcoming Clinical ...
finance.yahoo.com - November 9 at 10:25 AM
finance.yahoo.com logoApplied Therapeutics, Inc. (NASDAQ:APLT) is definitely on the radar of institutional investors who own 38% of the company
finance.yahoo.com - November 5 at 9:28 AM
benzinga.com logoMassive Insider Trade At Applied Therapeutics
benzinga.com - November 3 at 12:46 PM
finance.yahoo.com logoApplied Therapeutics to Present at the UBS Biopharma Conference 2023
finance.yahoo.com - November 2 at 10:03 AM
finance.yahoo.com logoApplied Therapeutics to Host Diabetic Cardiomyopathy Expert Forum with Key Opinion Leaders on Tuesday, November 7
finance.yahoo.com - November 1 at 9:00 AM
morningstar.com logoApplied Therapeutics Inc APLT
morningstar.com - November 1 at 12:14 AM
finance.yahoo.com logoApplied Therapeutics to Present Baseline Data from Phase 3 ARISE-HF Study Evaluating AT-001 at the 2023 EASD Annual Meeting
finance.yahoo.com - September 28 at 9:51 AM
marketwatch.com logoApplied Therapeutics Shares Rise 11% After Pre-NDA Meeting With FDA
marketwatch.com - September 6 at 12:47 PM
finance.yahoo.com logoApplied Therapeutics Announces Successful Pre-NDA Meeting with the FDA and Confirms Plans to Submit NDA for Govorestat (AT-007) for Treatment of Classic Galactosemia to FDA in Q4 2023
finance.yahoo.com - September 6 at 12:47 PM
msn.com logoApplied Therapeutics: Buy For Upcoming Pre-NDA Meeting (I Expect A Positive Outcome)
msn.com - August 17 at 9:30 AM
seekingalpha.com logoApplied Therapeutics GAAP EPS of -$0.37
seekingalpha.com - August 11 at 7:06 PM
finance.yahoo.com logoApplied Therapeutics Reports Second Quarter 2023 Financial Results
finance.yahoo.com - August 10 at 8:06 AM
fool.com logoApplied Therapeutics (NASDAQ: APLT)
fool.com - August 8 at 11:53 PM
finance.yahoo.com logoApplied Therapeutics to Present Baseline Data on the Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at the 2023 Annual Meeting of the American Diabetes Association
finance.yahoo.com - June 22 at 8:04 AM
finance.yahoo.com logoAPLT - Applied Therapeutics, Inc.
finance.yahoo.com - June 17 at 7:29 PM
finance.yahoo.com logoApplied Therapeutics to Present Data on AT-007 (Govorestat) Treatment in SORD Deficiency at the 2023 Annual Meeting of the Peripheral Nerve Society
finance.yahoo.com - June 15 at 10:20 AM
msn.com logoApplied Therapeutics govorestat gets orphan drug tag in EU for muscle disorder
msn.com - May 25 at 9:22 AM
finance.yahoo.com logoGovorestat (AT-007) Receives Orphan Medicinal Product Designation from the EMA for Treatment of SORD Deficiency
finance.yahoo.com - May 25 at 9:22 AM
finance.yahoo.com logoApplied Therapeutics Reports First Quarter 2023 Financial Results
finance.yahoo.com - May 11 at 8:40 AM
markets.businessinsider.com logo7 Hot Growth Stocks Poised to Triple in 2023
markets.businessinsider.com - May 5 at 2:56 PM
msn.com logoBaird Maintains Applied Therapeutics (APLT) Outperform Recommendation
msn.com - April 25 at 4:28 PM
msn.com logoApplied Therapeutics' Investigational Drug Shows Clinical Benefit In Rare Metabolic Disorder, Chalks Out FDA Submission Plans
msn.com - April 24 at 12:50 PM
msn.com logoApplied Therapeutics up 12% on $30M offering
msn.com - April 24 at 12:50 PM
finance.yahoo.com logoApplied Therapeutics, Inc. Announces $30 Million Private Placement of Equity
finance.yahoo.com - April 24 at 7:50 AM
finance.yahoo.com logoApplied Therapeutics Announces Clinical Benefit of Govorestat (AT-007) in ACTION-Galactosemia Kids Trial; Company Plans to Meet with FDA Regarding Potential NDA Submission
finance.yahoo.com - April 24 at 7:50 AM
finance.yahoo.com logoApplied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial Results
finance.yahoo.com - March 23 at 9:32 AM
finance.yahoo.com logoQuite a few insiders invested in Applied Therapeutics, Inc. (NASDAQ:APLT) last year which is positive news for shareholders
finance.yahoo.com - March 18 at 1:13 PM
finance.yahoo.com logoApplied Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
finance.yahoo.com - March 1 at 7:17 AM
finance.yahoo.com logoApplied Therapeutics Reveals Pivotal Study Data In Hereditary Neuropathy
finance.yahoo.com - February 24 at 4:49 AM
msn.com logoApplied Therapeutics rises ~10% as AT-007 shows efficacy in phase 3 trial for muscle disorder
msn.com - February 16 at 8:52 AM
finance.yahoo.com logoApplied Therapeutics Announces Positive Sorbitol Reduction Data From the Ongoing Phase 3 INSPIRE Trial in Sorbitol Dehydrogenase (SORD) Deficiency
finance.yahoo.com - February 16 at 8:52 AM
finance.yahoo.com logoApplied Therapeutics to Present at the SVB Securities Global Biopharma Conference
finance.yahoo.com - February 9 at 8:42 AM
marketbeat.com logoShort Interest in Applied Therapeutics, Inc. (NASDAQ:APLT) Increases By 70.9%
marketbeat.com - January 27 at 5:52 AM
forbes.com logoApplied Therapeutics
forbes.com - January 21 at 1:24 AM
msn.com logoWhy Applied Therapeutics Shares Are Seeing Blue Skies
msn.com - January 4 at 1:46 PM
uk.finance.yahoo.com logoApplied Therapeutics, Inc. (APLT)
uk.finance.yahoo.com - January 4 at 12:12 AM
finance.yahoo.com logoApplied Therapeutics Reports Third Quarter 2022 Financial Results
finance.yahoo.com - November 9 at 10:37 AM
finance.yahoo.com logoApplied Therapeutics Announces Multiple Data Presentations at the American Heart Association Scientific Sessions November 5-7, 2022
finance.yahoo.com - October 31 at 9:59 AM
finance.yahoo.com logoApplied Therapeutics Announces Full Enrollment in the Registrational Phase 3 ARISE-HF Trial of AT-001 in Diabetic Cardiomyopathy
finance.yahoo.com - October 25 at 12:06 PM
finance.yahoo.com logoInsiders who purchased Applied Therapeutics, Inc. (NASDAQ:APLT) earlier this year lose an additional US$86k as the stock sinks to US$0.62
finance.yahoo.com - October 9 at 11:56 AM
marketwatch.com logoApplied Therapeutics Down 33% on Clinical Trial Update
marketwatch.com - October 6 at 4:14 PM
finance.yahoo.com logoApplied Therapeutics' Lead Candidate Pediatric Study Failed To Reach Statistical Significance
finance.yahoo.com - October 6 at 4:14 PM
markets.businessinsider.com logoApplied Therapeutics: AT-007 Trial Shows Positive Data Trend; Yet To Reach Statistical Significance
markets.businessinsider.com - October 6 at 11:12 AM
finance.yahoo.com logoApplied Therapeutics Announces Positive Data Trend in AT-007 ACTION-Galactosemia Kids Pediatric Trial; Trial Will Continue to 18 Months in Blinded Format
finance.yahoo.com - October 6 at 11:12 AM
finance.yahoo.com logoBears are Losing Control Over Applied Therapeutics Inc. (APLT), Here's Why It's a 'Buy' Now
finance.yahoo.com - September 2 at 6:42 PM
nasdaq.com logoWe're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate
nasdaq.com - August 16 at 10:55 PM
msn.com logoRecap: Applied Therapeutics Q2 Earnings
msn.com - August 12 at 7:38 PM
Get Applied Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter.



APLT Media Mentions By Week

APLT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

APLT
News Sentiment
▼
1.89

0.75
▲
Average
Medical
News Sentiment

APLT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

APLT Articles
This Week
▼
1

0
▲
APLT Articles
Average Week

Get Applied Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:APLT) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -